{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:23:40Z","timestamp":1778221420809,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007659","name":"Bayer Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clcc.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T11:52:11Z","timestamp":1600170731000},"page":"84-95.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1"],"prefix":"10.1016","volume":"20","author":[{"given":"Heinz-Josef","family":"Lenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillem","family":"Argiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Tejpar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Braunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey V.","family":"Salnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogsen","family":"Gabrielyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"H\u00f6fler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kitzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2020.09.003_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.clcc.2020.09.003_bib3","first-page":"613","article-title":"Current and future biomarkers in colorectal cancer","volume":"30","author":"Zarkavelis","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.clcc.2020.09.003_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clcc.2020.09.003_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11912-011-0162-3","article-title":"Predictive and prognostic markers in colorectal cancer","volume":"13","author":"George","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clcc.2020.09.003_bib6","first-page":"12","article-title":"The developing story of predictive biomarkers in colorectal cancer","volume":"9","author":"Boussios","year":"2019","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.clcc.2020.09.003_bib7","doi-asserted-by":"crossref","first-page":"112103","DOI":"10.18632\/oncotarget.22783","article-title":"Hypermutation and microsatellite instability in gastrointestinal cancers","volume":"8","author":"Yuza","year":"2017","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"10.1016\/j.clcc.2020.09.003_bib8","first-page":"13","article-title":"Biomarkers of angiogenesis in colorectal cancer","volume":"7","author":"Mousa","year":"2015","journal-title":"Biomark Cancer"},{"key":"10.1016\/j.clcc.2020.09.003_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14737140.2018.1428092","article-title":"The role of tumor angiogenesis as a therapeutic target in colorectal cancer","volume":"18","author":"Battaglin","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clcc.2020.09.003_bib10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"15 Suppl","key":"10.1016\/j.clcc.2020.09.003_bib11","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/jco.2015.33.15_suppl.3558","article-title":"Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial","volume":"33","author":"Teufel","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.09.003_bib12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.18.02258","article-title":"Impact of consensus molecular subtype on survival in patients with metastatic colorectal cancer: results from CALGB\/SWOG 80405 (alliance)","volume":"37","author":"Lenz","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"15 Suppl","key":"10.1016\/j.clcc.2020.09.003_bib13","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1200\/JCO.2017.35.15_suppl.3510","article-title":"Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial","volume":"35","author":"Stintzing","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"15 Suppl","key":"10.1016\/j.clcc.2020.09.003_bib14","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.2017.35.15_suppl.3509","article-title":"Clinical utility of colon cancer molecular subtypes: validation of two main colorectal molecular classifications on the PETACC-8 phase III trial cohort","volume":"35","author":"Marisa","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.09.003_bib15","doi-asserted-by":"crossref","first-page":"18698","DOI":"10.18632\/oncotarget.24617","article-title":"Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer","volume":"9","author":"Okita","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.clcc.2020.09.003_bib16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/annonc\/mdy241","article-title":"Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study","volume":"29","author":"Van Cutsem","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2020.09.003_bib17","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1038\/s41598-020-69083-y","article-title":"ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing","volume":"10","author":"Buechler","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clcc.2020.09.003_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/path.5051","article-title":"Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies","volume":"245","author":"Alderdice","year":"2018","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.clcc.2020.09.003_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdz052","article-title":"Context matters: consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials","volume":"30","author":"Fontana","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2020.09.003_bib20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/cas.13972","article-title":"Clinical utility of circulating tumor DNA for colorectal cancer","volume":"110","author":"Osumi","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clcc.2020.09.003_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijc.32510","article-title":"Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan-cancer setting","volume":"146","author":"Mardinian","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2020.09.003_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jmoldx.2015.02.001","article-title":"Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility?","volume":"17","author":"Gold","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.clcc.2020.09.003_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clcc.2020.09.003_bib24","doi-asserted-by":"crossref","first-page":"17717","DOI":"10.1038\/srep17717","article-title":"A\u00a0plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancer","volume":"5","author":"Bai","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.clcc.2020.09.003_bib25","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1158\/1078-0432.CCR-19-0818","article-title":"Angiogenic factor and cytokine analysis among patients treated with adjuvant VEGFR TKIs in resected renal cell carcinoma","volume":"25","author":"Xu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2020.09.003_bib26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(15)00138-2","article-title":"Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial","volume":"16","author":"Tabernero","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820301274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820301274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:06:42Z","timestamp":1761520002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002820301274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1533002820301274"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2020.09.003","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}